Trial Profile
A phase I study evaluating pharmacokinetics and pharmacodynamics of multiple doses of anacetrapib in black compared to white healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Jul 2018
Price :
$35
*
At a glance
- Drugs Anacetrapib (Primary)
- Indications Dyslipidaemias; Hypercholesterolaemia; Hyperlipidaemia
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 29 Jul 2018 New trial record
- 20 Jul 2018 Results published in the Journal of Clinical Pharmacology